All Stories

  1. The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae
  2. Crystal structure of CTX-M-15 extended-spectrum beta-lactamase in complex with avibactam (NXL104)
  3. Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole
  4. In VitroAntibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates
  5. Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β-Lactamase Inhibitor
  6. In vitro activity of the  -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
  7. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum  -lactamases and carbapenemases
  8. P794 The efficacy of ceftazidime combined with NXL104, a novel β-lactamase inhibitor, in a mouse model of kidney infections induced by β-lactamase producing Enterobacteriaceae
  9. Enzymatic activity of two caspases related to interleukin‐1β‐converting enzyme
  10. Use of monoclonal antibodies to study interleukin ‐1β‐converting enzyme expression: only precursor forms are detected in interleukin‐1β‐secreting cells
  11. CD3.TCR1, A Human CD3 epitope expressed on viable γδ lymphocytes exclusively
  12. Molecular characterization of human T cell receptor α chains including a Vδ1‐encoded variable segment
  13. CD1c as a target recognition structure for human T lymphocytes: Analysis with peripheral blood γ/δ cells
  14. Regulatory effects of IgG-BF on hybridoma B cells. Molecular characterization of variant cell lines
  15. Cloned CD3+ TcRα/β− TiγA− peripheral blood lymphocytes compared to the Ti γA+ counterparts: structural differences of the γ/δ receptor and functional heterogeneity